Treatment of night eating syndrome with topiramate: dawn of a new day.
Rena
R
Cooper-Kazaz
D000927:Anticonvulsants / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D002940:Circadian Rhythm; D003511:Cyclohexanols / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005247:Feeding Behavior / Q000187:drug effects; D001068:Feeding and Eating Disorders / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy* / Q000523:psychology; D000077236:Topiramate; D000069470:Venlafaxine Hydrochloride
D000927:Anticonvulsants; D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000077236:Topiramate; D005632:Fructose; D000069470:Venlafaxine Hydrochloride